Literature DB >> 4595312

BCG immunotherapy of rat tumors of defined immunogenicity.

R W Baldwin, M V Pimm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4595312

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  7 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Immunoprophylaxis and therapy of grafted rat colonic carcinoma.

Authors:  M S Martin; F Martin; E Justrabo; M F Michel; A Lagneau
Journal:  Gut       Date:  1977-03       Impact factor: 23.059

3.  Therapeutic studies with BCG, cyclophosphamide and surgery alone and in combination on the autochthonous mammary carcinoma of the rat.

Authors:  E Storch; H H Fiebig; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

4.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

5.  A preliminary report on the effects of methanol extraction residue of BCG (MER) on cancer patients.

Authors:  E Robinson; A Bartal; Y Cohen; R Haasz
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

6.  Effect of BCG on cell-mediated cytotoxicity and serum blocking factor during growth of rat hepatoma.

Authors:  M J Embleton
Journal:  Br J Cancer       Date:  1976-06       Impact factor: 7.640

7.  Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.

Authors:  N Creau-Goldberg; J C Salomon
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.